Vaccinul CureVac împotriva COVID-19 a generat un răspuns imun în prima fază a studiului clinic Digi24 - 02 Nov 2020 Vaccinul CureVac împotriva COVID-19 a generat un răspuns imun în prima fază a studiului clinic ... More
CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech CureVac - 19 May 2023 CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech ... More
German Federal Patent Court changes its mind on CureVac mRNA patent JUVE Patent - 19 Dec 2023 German Federal Patent Court changes its mind on CureVac mRNA patent ... More
Coronavirus: Commission offers financing to innovative vaccines company CureVac European Union - 16 Mar 2020 Coronavirus: Commission offers financing to innovative vaccines company CureVac ... More
German court quashes CureVac patent after challenge by BioNTech Reuters - 19 Dec 2023 German court quashes CureVac patent after challenge by BioNTech ... More
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines MD Anderson Cancer Center - 16 Apr 2024 MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines ... More
CureVac sues BioNTech over mRNA technology Nature - 09 Aug 2022 CureVac sues BioNTech over mRNA technology ... More
CureVac announces positive Phase II Covid-19 vaccine trial data Clinical Trials Arena - 09 Jan 2024 CureVac announces positive Phase II Covid-19 vaccine trial data ... More
Amid BioNTech legal fight, CureVac takes a loss as German court invalidates patent Fierce Pharma - 19 Dec 2023 Amid BioNTech legal fight, CureVac takes a loss as German court invalidates patent ... More
CureVac, chasing Moderna mRNA flu shot, hits similar problems Fierce Biotech - 04 Apr 2024 CureVac, chasing Moderna mRNA flu shot, hits similar problems ... More
CureVac vaccine flop a huge blow DW (English) - 17 Jun 2021 CureVac vaccine flop a huge blow ... More
Düsseldorf Regional Court waits for validity judgments in CureVac v BioNTech JUVE Patent - 17 Aug 2023 Düsseldorf Regional Court waits for validity judgments in CureVac v BioNTech ... More
CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma CureVac - 20 Jun 2023 CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma ... More
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights Reuters - 25 Apr 2024 Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights ... More
CureVac touts 'progress' in vaccine patent case against BioNTech Fierce Pharma - 28 Sep 2023 CureVac touts 'progress' in vaccine patent case against BioNTech ... More
CureVac files vaccine patent infringement claim against BioNTech in Düsseldorf JUVE Patent - 07 Jul 2022 CureVac files vaccine patent infringement claim against BioNTech in Düsseldorf ... More
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government CureVac - 11 Apr 2022 CureVac and GSK Enter into Pandemic Preparedness Contract with German Government ... More
CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board CureVac - 20 Jun 2023 CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board ... More
CureVac Announces Financial Results for the Third Quarter of 2022 and Provides Business Update CureVac - 16 Nov 2022 CureVac Announces Financial Results for the Third Quarter of 2022 and Provides Business Update ... More